Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
Eli Lilly (NYSE: LLY) sells a broad vary of prescription drugs treating varied ailments, however one portfolio specifically has helped its earnings and its inventory soar in latest occasions. It consists of the corporate’s weight reduction medication: Mounjaro, authorised for kind 2 diabetes but additionally prescribed off-label for weight management, and Zepbound, particularly authorised for … Read more